STING1 and viral infectious disease: While CDNs have minimal immunological influence in STING-deficient cancer cells, through secretion or cell lysis during viral infection, c-di-AMP is released and ingested by extrinsic phagocytes (e.g dendritic cells), activating the STING pathway and promoting anti-tumor immunity (73).